Drug Type T-lymphocyte cell therapy |
Synonyms InfiniTIL |
Target- |
Mechanism T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Rootpath Genomics, Inc.Startup |
Active Organization Rootpath Genomics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | CN | Rootpath Genomics, Inc.Startup | 25 Mar 2022 |
Solid tumor | Preclinical | US | Rootpath Genomics, Inc.Startup | 25 Mar 2022 |